Targeting transcription in heart failure via CDK7/12/13 inhibition
<jats:title>Abstract</jats:title><jats:p>Heart failure with reduced ejection fraction (HFrEF) is associated with high mortality, highlighting an urgent need for new therapeutic strategies. As stress-activated cardiac signaling cascades converge on the nucleus to drive maladaptive g...
Main Authors: | Hsu, Austin, Duan, Qiming, Day, Daniel S, Luo, Xin, McMahon, Sarah, Huang, Yu, Feldman, Zachary B, Jiang, Zhen, Zhang, Tinghu, Liang, Yanke, Alexanian, Michael, Padmanabhan, Arun, Brown, Jonathan D, Lin, Charles Y, Gray, Nathanael S, Young, Richard A, Bruneau, Benoit G, Haldar, Saptarsi M |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2023
|
Online Access: | https://hdl.handle.net/1721.1/147016 |
Similar Items
-
Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors
by: Kalan, Sampada, et al.
Published: (2018) -
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
by: Olson, Calla M, et al.
Published: (2018) -
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
by: Wang, Yubao, et al.
Published: (2017) -
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
by: Zhang, Tinghu, et al.
Published: (2017) -
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
by: Kwiatkowski, Nicholas P., et al.
Published: (2015)